Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2022-05-05 00:00:00 ET · period of report 2022-05-04 · accession 0001209191-22-027344 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-05-05 | 2022-05-04 | KPTI | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $6.23 | -28.5K | 633.4K | -4% | -$177.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-04 | S | D | 633 | $6.26 | 661,317 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-04 | S | D | 27,869 | $6.23 | 633,448 | D | — | — |